{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:15:00Z","timestamp":1790014500076,"version":"4.0.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T00:00:00Z","timestamp":1749340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T00:00:00Z","timestamp":1749340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-04883-6","type":"journal-article","created":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T16:43:03Z","timestamp":1749400983000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The relationship between homocysteine levels and blood pressure variability with early renal injury marker NGAL in patients with H-type hypertension"],"prefix":"10.1186","volume":"25","author":[{"given":"Xuanhao","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiulan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runrun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,8]]},"reference":[{"key":"4883_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwae022","author":"D-F Wu","year":"2024","unstructured":"Wu D-F, Yin R-X, Deng J-L. Homocysteine, hyperhomocysteinemia and H-type hypertension. Eur J Prev Cardiol. 2024. https:\/\/doi.org\/10.1093\/eurjpc\/zwae022.","journal-title":"Eur J Prev Cardiol"},{"key":"4883_CR2","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.23-488","author":"X Zhang","year":"2024","unstructured":"Zhang X, Guo B, Zhu H, Li D, Zhao Y, Liu Q, Hou J. H-type hypertension status and influencing factors of the elderly people over 80 years old based on random forest model. Int Heart J. 2024. https:\/\/doi.org\/10.1536\/ihj.23-488.","journal-title":"Int Heart J"},{"issue":"1","key":"4883_CR3","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1186\/S12872-021-02151-X","volume":"21","author":"X-L Qian","year":"2021","unstructured":"Qian X-L, Cao H, Zhang J, Gu Z-H, Tang W-Q, Shen L, Hu J, Yao Z-F, Zhang L, Tang M-N, Lv X, Zhou J, Jin X, Hong B, Cui Z, Ge J. The prevalence, relative risk factors and MTHFR C677T genotype of H type hypertension of the elderly hypertensives in Shanghai, China: a cross-section study: prevalence of H type hypertension. BMC Cardiovasc Disord. 2021;21(1):376. https:\/\/doi.org\/10.1186\/S12872-021-02151-X.","journal-title":"BMC Cardiovasc Disord"},{"key":"4883_CR4","doi-asserted-by":"publisher","unstructured":"Long T, Zheng LW, Ding Z, Tao Y, Hong X. (2024). H-type hypertension is a risk factor for chronic kidney disease: a case-control study. https:\/\/doi.org\/10.21203\/rs.3.rs-3992934\/v1","DOI":"10.21203\/rs.3.rs-3992934\/v1"},{"key":"4883_CR5","doi-asserted-by":"publisher","unstructured":"Cao P, Xu R. A14749 hyperhomocysteinemia is an independent risk factor for renal damage in the elderly population. J Hypertens. 2018;36. https:\/\/doi.org\/10.1097\/01.HJH.0000548941.53277.13.","DOI":"10.1097\/01.HJH.0000548941.53277.13"},{"key":"4883_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfae184","author":"LD Browne","year":"2024","unstructured":"Browne LD, Alamin M, Miri H, Hall H, Tandan RB, Sexton M, D. J., Stack AG. Prevalence, awareness, treatment, and control of hypertension in community dwelling older adults with chronic kidney disease: the Irish longitudinal study on ageing. NDT Plus. 2024. https:\/\/doi.org\/10.1093\/ckj\/sfae184.","journal-title":"NDT Plus"},{"key":"4883_CR7","doi-asserted-by":"publisher","unstructured":"\u041a\u0440\u0443\u0433\u043b\u043e\u0432\u0430 \u041c\u041f, \u0418\u0432\u0430\u043d\u043e\u0432 \u0410\u0412, \u0412\u0432\u0435\u0434\u0435\u043d\u0441\u043a\u0430\u044f \u041e\u042e, \u041a\u0443\u0431\u0430\u0442\u0438\u0435\u0432 \u0410\u0410. (2018). \u0413\u0438\u043f\u0435\u0440\u0433\u043e\u043c\u043e\u0446\u0438\u0441\u0442\u0435\u0438\u043d\u0435\u043c\u0438\u044f \u0438 \u0445\u0440\u043e\u043d\u0438\u0447\u0435\u0441\u043a\u0430\u044f \u0431\u043e\u043b\u0435\u0437\u043d\u044c \u043f\u043e\u0447\u0435\u043a. 62(4), 195\u2013201. https:\/\/doi.org\/10.25557\/0031-2991.2018.04.195-201","DOI":"10.25557\/0031-2991.2018.04.195-201"},{"key":"4883_CR8","doi-asserted-by":"publisher","unstructured":"Huan Y, Cohen DL, Townsend RR. (2015). Pathophysiology of Hypertension in Chronic Kidney Disease (pp. 163\u2013169). Academic Press. https:\/\/doi.org\/10.1016\/B978-0-12-411602-3.00014-7","DOI":"10.1016\/B978-0-12-411602-3.00014-7"},{"key":"4883_CR9","doi-asserted-by":"publisher","unstructured":"Red\u00f3n J. (2023). Renal and Heart Failure Interrelationship in Hypertension (pp. 127\u2013137). Springer International Publishing. https:\/\/doi.org\/10.1007\/978-3-031-39315-0_9","DOI":"10.1007\/978-3-031-39315-0_9"},{"key":"4883_CR10","doi-asserted-by":"publisher","unstructured":"Li S, Zhu J, Wu L, Peng L, Luo Y, Zhao Y, Dong R, Chen L, Tang X, Liu J. (2018). The association between plasma homocysteine and ambulatory blood pressure variability in patients with untreated hypertension. Clinica chimica acta; international journal of clinical chemistry, 477, 32\u20138. https:\/\/doi.org\/10.1016\/j.cca.2017.11.042","DOI":"10.1016\/j.cca.2017.11.042"},{"key":"4883_CR11","doi-asserted-by":"publisher","unstructured":"Waly Y. (2021). Medical and therapeutic aspects of hyperhomocysteinemia. In Hyperhomocysteinemia: Medical and Therapeutic Aspects https:\/\/doi.org\/10.1007\/978-3-030-57839-8_22","DOI":"10.1007\/978-3-030-57839-8_22"},{"issue":"7","key":"4883_CR12","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1111\/jch.14265","volume":"23","author":"R Carnagarin","year":"2021","unstructured":"Carnagarin R, Nolde JM, Ward NC, Lugo-Gavidia LM, Chan J, Robinson S, Jose A, Joyson A, Azzam O, Kiuchi G, Mwipatayi M, B. P., Schlaich MP. HCY predicts vascular target organ damage in hypertension and May serve as guidance for first-line antihypertensive therapy. J Clin Hypertens (Greenwich Conn). 2021;23(7):1380\u20139. https:\/\/doi.org\/10.1111\/jch.14265.","journal-title":"J Clin Hypertens (Greenwich Conn)"},{"key":"4883_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/cdt3.127","author":"F Zhao","year":"2024","unstructured":"Zhao F, Yang ZJ, C., Huang R. Effects of long-term blood pressure variability on renal function in community population. Chronic Dis Translational Med. 2024. https:\/\/doi.org\/10.1002\/cdt3.127.","journal-title":"Chronic Dis Translational Med"},{"issue":"5","key":"4883_CR14","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1097\/HJH.0000000000001707","volume":"36","author":"G Bilo","year":"2018","unstructured":"Bilo G, Parati G. Blood pressure variability and kidney disease: another vicious circle? J Hypertens. 2018;36(5):1019\u201321. https:\/\/doi.org\/10.1097\/HJH.0000000000001707.","journal-title":"J Hypertens"},{"issue":"9","key":"4883_CR15","first-page":"2226","volume":"21","author":"L Yin","year":"2017","unstructured":"Yin L, Yan W, Guo Z, Zhou F, Zhang H. Relation between blood pressure variability and early renal damage in hypertensive patients. Eur Rev Med Pharmacol Sci. 2017;21(9):2226\u201331. https:\/\/pubmed.ncbi.nlm.nih.gov\/28537660\/.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"12","key":"4883_CR16","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1097\/HJH.0000000000001825","volume":"36","author":"S Borrelli","year":"2018","unstructured":"Borrelli S, Garofalo C, Mallamaci F, Tripepi G, Stanzione G, Provenzano M, Conte G, De Nicola L, Zoccali C, Minutolo R. Short-term blood pressure variability in nondialysis chronic kidney disease patients: correlates and prognostic role on the progression of renal disease. J Hypertens. 2018;36(12):2398\u2013405. https:\/\/doi.org\/10.1097\/HJH.0000000000001825.","journal-title":"J Hypertens"},{"key":"4883_CR17","doi-asserted-by":"publisher","DOI":"10.46648\/gnj.270","author":"H Duru","year":"2021","unstructured":"Duru H, Kara E. The relationship between blood pressure variability and renal progression in hypertensive patients with chronic kidney disease. Gevher Nesibe J IESDR. 2021. https:\/\/doi.org\/10.46648\/gnj.270.","journal-title":"Gevher Nesibe J IESDR"},{"key":"4883_CR18","doi-asserted-by":"publisher","unstructured":"Ko Y, Jhee JH. (2023). Short-term blood pressure variability as a potential therapeutic target for kidney disease. Clinical Hypertension, 29. https:\/\/doi.org\/10.1186\/s40885-023-00248-3","DOI":"10.1186\/s40885-023-00248-3"},{"key":"4883_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/jch.14824","author":"S Wu","year":"2024","unstructured":"Wu S, Li S, Jing H, Jie Y, Wei C, Wei L, Zhu S, Chen S, Chen M, Li J. The association between blood pressure variability and renal damage in patients with primary aldosteronism. J Clin Hypertens. 2024. https:\/\/doi.org\/10.1111\/jch.14824.","journal-title":"J Clin Hypertens"},{"key":"4883_CR20","doi-asserted-by":"publisher","unstructured":"Wang G, Ma K, Ma Z, Guo X, Wang Y. L., Ma L, Qi C, Li Y, Zhou X-H. Short-term blood pressure variability and outcomes in non-dialysis chronic kidney disease. Front Med. 2022;9. https:\/\/doi.org\/10.3389\/fmed.2022.911205.","DOI":"10.3389\/fmed.2022.911205"},{"issue":"1","key":"4883_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5414\/CN109311","volume":"90","author":"T Sahutoglu","year":"2018","unstructured":"Sahutoglu T, Sakaci T. Diastolic blood pressure variability in 24 hour-ABPM and outcomes of chronic kidney disease. Clin Nephrol. 2018;90(1):46\u201352. https:\/\/doi.org\/10.5414\/CN109311.","journal-title":"Clin Nephrol"},{"key":"4883_CR22","doi-asserted-by":"publisher","unstructured":"Dong L, Liu J, Qin Y, Yang WJ, Nie L, Liu HN, Hu QH, Sun Y, Cao WY. (2023). Relationship between ambulatory arterial stiffness index and the severity of angiographic atherosclerosis in patients with H-type hypertension and coronary artery disease. Clinical and experimental hypertension (New York, N.Y.: 1993), 45(1), 2228517. https:\/\/doi.org\/10.1080\/10641963.2023.2228517","DOI":"10.1080\/10641963.2023.2228517"},{"key":"4883_CR23","doi-asserted-by":"publisher","unstructured":"Jiang D, Matsuzaki M, Kawagoe Y, Kitamura K, Tsuruda T, Kaikita K, Asada Y, Kato J. Analysis of mechanisms for increased blood pressure variability in rats continuously infused with angiotensin II. J renin-angiotensin-aldosterone System: JRAAS. 2023;2023(4201342). https:\/\/doi.org\/10.1155\/2023\/4201342.","DOI":"10.1155\/2023\/4201342"},{"key":"4883_CR24","doi-asserted-by":"publisher","unstructured":"Ahmad H, Khan H, Haque S, Ahmad S, Srivastava N, Khan A. (2023). Angiotensin-Converting Enzyme and Hypertension: A Systemic Analysis of Various ACE Inhibitors, Their Side Effects, and Bioactive Peptides as a Putative Therapy for Hypertension. Journal of the renin-angiotensin-aldosterone system: JRAAS, 2023, 7890188. https:\/\/doi.org\/10.1155\/2023\/7890188","DOI":"10.1155\/2023\/7890188"},{"key":"4883_CR25","doi-asserted-by":"publisher","DOI":"10.1177\/14703203241274052","author":"T Jing","year":"2024","unstructured":"Jing T, Zeng J. Aldosterone\u2013cortisol co-secretion in different adrenal tumors: A case series. J Renin\u2013Angiotensin\u2013Aldosterone Syst. 2024. https:\/\/doi.org\/10.1177\/14703203241274052., 25, Article 14703203241274052.","journal-title":"J Renin\u2013Angiotensin\u2013Aldosterone Syst"},{"key":"4883_CR26","doi-asserted-by":"publisher","unstructured":"Isordia-Salas I, Santiago-Germ\u00e1n D, Jim\u00e9nez-Alvarado RM, Lea\u00f1os-Miranda A. Genetic variants associated with high susceptibility of premature ischemic stroke. J renin-angiotensin-aldosterone System: JRAAS. 2023;2023(9002021). https:\/\/doi.org\/10.1155\/2023\/9002021.","DOI":"10.1155\/2023\/9002021"},{"issue":"11","key":"4883_CR27","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1515\/CCLM.2003.216","volume":"41","author":"C Stehouwer","year":"2003","unstructured":"Stehouwer C, Guldener C. Does HCY Cause Hypertension? 2003;41(11):1408\u201311. https:\/\/doi.org\/10.1515\/CCLM.2003.216.","journal-title":"Does HCY Cause Hypertension?"},{"issue":"12","key":"4883_CR28","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/ajh\/hpaa086","volume":"33","author":"N Gao","year":"2020","unstructured":"Gao N, Zhang Y, Li L, Lei L, Cao P, Zhao X, Lin L, Xu R. Hyperhomocysteinemia-induced oxidative stress aggravates renal damage in hypertensive rats. Am J Hypertens. 2020;33(12):1127\u201335. https:\/\/doi.org\/10.1093\/ajh\/hpaa086.","journal-title":"Am J Hypertens"},{"key":"4883_CR29","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1111\/jch.14265","volume":"23","author":"R Carnagarin","year":"2021","unstructured":"Carnagarin R, Nolde JM, Ward NC, et al. HCY predicts vascular target organ damage in hypertension and May serve as guidance for first-line antihypertensive therapy. J Clin Hypertens. 2021;23:1380\u20139. https:\/\/doi.org\/10.1111\/jch.14265.","journal-title":"J Clin Hypertens"},{"issue":"2","key":"4883_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/jch.12881","volume":"19","author":"Z Ye","year":"2017","unstructured":"Ye Z, Wang C, Zhang Q, Li Y, Zhang J, Ma X, Peng H, Lou T. Prevalence of Homocysteine-Related hypertension in patients with chronic kidney disease. J Clin Hypertens (Greenwich Conn). 2017;19(2):151\u201360. https:\/\/doi.org\/10.1111\/jch.12881.","journal-title":"J Clin Hypertens (Greenwich Conn)"},{"key":"4883_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/978-981-10-7632-9_4","volume-title":"Homocysteinemia and hypertension","author":"S Bhargava","year":"2018","unstructured":"Bhargava S. Homocysteinemia and hypertension. Singapore: Springer; 2018. pp. 37\u201341. https:\/\/doi.org\/10.1007\/978-981-10-7632-9_4."},{"key":"4883_CR32","doi-asserted-by":"crossref","unstructured":"Pezzati P, Balboni F, Graziani MS. (2010). Iperomocisteinemia e rischio cardiovascolare: stato dell\u2019arte. 34(3), 173\u2013186. https:\/\/iris.univr.it\/handle\/11562\/387837","DOI":"10.1080\/03098260903093653"},{"issue":"36","key":"4883_CR33","first-page":"1489","volume":"127","author":"C Monnerat","year":"1997","unstructured":"Monnerat C, Hayoz D. Homocysteine and venous thromboembolism. Schweizerische Medizinische Wochenschrift. 1997;127(36):1489\u201396. https:\/\/europepmc.org\/article\/MED\/9309844.","journal-title":"Schweizerische Medizinische Wochenschrift"},{"issue":"7","key":"4883_CR34","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.3390\/nu14071412","volume":"14","author":"WA Herrmann","year":"2022","unstructured":"Herrmann WA, Herrmann M. The controversial role of HCY and vitamin B deficiency in cardiovascular diseases. Nutrients. 2022;14(7):1412. https:\/\/doi.org\/10.3390\/nu14071412.","journal-title":"Nutrients"},{"issue":"4","key":"4883_CR35","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s00394-023-03087-y","volume":"62","author":"X-T Lu","year":"2023","unstructured":"Lu X-T, Mo Q-W, Huang B, Huang Z, Luo Y, Maierhaba W, He T, Li S, Huang R, Yang M-T, Liu X-Z, Liu Z-Y, Chen S, Fang A-P, Zhang XG, Zhu H. Effects of low-dose B vitamins plus betaine supplementation on Lowering homocysteine concentrations among Chinese adults with hyperhomocysteinemia: a randomized, double-blind, controlled preliminary clinical trial. Eur J Nutr. 2023;62(4):1599\u2013610. https:\/\/doi.org\/10.1007\/s00394-023-03087-y.","journal-title":"Eur J Nutr"},{"issue":"8","key":"4883_CR36","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/S00394-008-0752-5","volume":"47","author":"C-H Cheng","year":"2008","unstructured":"Cheng C-H, Huang Y-C, Chen F-P, Chou M-C, Tsai T-P. B-vitamins, homocysteine and gene polymorphism in adults with fasting or post-methionine loading hyperhomocysteinemia. Eur J Nutr. 2008;47(8):491\u20138. https:\/\/doi.org\/10.1007\/S00394-008-0752-5.","journal-title":"Eur J Nutr"},{"issue":"8","key":"4883_CR37","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.3390\/ijms18081682","volume":"18","author":"J Kaur","year":"2017","unstructured":"Kaur J, Young BE, Fadel PJ. Sympathetic overactivity in chronic kidney disease: consequences and mechanisms. Int J Mol Sci. 2017;18(8):1682. https:\/\/doi.org\/10.3390\/ijms18081682.","journal-title":"Int J Mol Sci"},{"key":"4883_CR38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.autneu.2017.01.002","volume":"204","author":"E Lambert","year":"2017","unstructured":"Lambert E, Schlaich M. The role of renal sympathetic nerves in Ischaemia-Reperfusion injury. Auton Neurosci. 2017;204:105\u201311. https:\/\/doi.org\/10.1016\/j.autneu.2017.01.002.","journal-title":"Auton Neurosci"},{"issue":"9","key":"4883_CR39","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.bbamcr.2012.06.014","volume":"1823","author":"N Paragas","year":"2012","unstructured":"Paragas N, Qiu A, Hollmen M, et al. NGAL-Siderocalin in kidney disease. Biochim Biophys Acta. 2012;1823(9):1451\u20138. https:\/\/doi.org\/10.1016\/j.bbamcr.2012.06.014.","journal-title":"Biochim Biophys Acta"},{"key":"4883_CR40","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3389\/fphys.2012.00134","volume":"3","author":"CS Zuern","year":"2012","unstructured":"Zuern CS, Rizas KD, Eick C, et al. Effects of renal sympathetic denervation on 24-Hour blood pressure variability. Front Physiol. 2012;3:134. https:\/\/doi.org\/10.3389\/fphys.2012.00134.","journal-title":"Front Physiol"},{"issue":"1S","key":"4883_CR41","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1016\/j.chest.2020.03.012","volume":"158","author":"X Wang","year":"2020","unstructured":"Wang X, Cheng Z. Cross-Sectional studies: strengths, weaknesses, and recommendations. Chest. 2020;158(1S):S65\u201371. https:\/\/doi.org\/10.1016\/j.chest.2020.03.012.","journal-title":"Chest"},{"key":"4883_CR42","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10869-018-09613-8","volume":"34","author":"PE Spector","year":"2019","unstructured":"Spector PE. Do not cross me: optimizing the use of cross-sectional designs. J Bus Psychol. 2019;34:125\u201337. https:\/\/doi.org\/10.1007\/s10869-018-09613-8.","journal-title":"J Bus Psychol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04883-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-04883-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04883-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T16:43:04Z","timestamp":1749400984000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-04883-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,8]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4883"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-04883-6","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,8]]},"assertion":[{"value":"31 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Review Board of Xijing 986 Hospital, Air Force Medical University, and written informed consent was obtained from all participants prior to enrollment. This study was conducted be in compliance with the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"439"}}